Antibiotice S.A. (BVB:ATB)

Market Cap	1.55B -9.1%
Revenue (ttm)	648.96M -1.4%
Net Income	56.90M -38.3%
EPS	0.08 -38.4%
Shares Out	671.34M
PE Ratio	27.26
Forward PE	n/a
Dividend	0.02 (0.89%)
Ex-Dividend Date	Sep 25, 2025

Volume	531,779
Average Volume	244,610
Open	2.350
Previous Close	2.350
Day's Range	2.300 - 2.350
52-Week Range	1.750 - 2.725
Beta	0.27
RSI	29.66
Earnings Date	Feb 26, 2026

About Antibiotice

Antibiotice S.A. produces and sells medicinal products in Romania and internationally. The company offers generic prescription medicines comprising anti-infectives, including drugs for the treatment of tuberculosis, as well as cardiovascular drugs, digestive tract and metabolism class, preparations for the treatment of gynecological diseases, and dermatological and central nervous system preparations; generic non-prescription medicines, including food supplements, cosmetics, and medical devices; active substances; biofertilizers; biocides for d...

• Industry: Pharmaceutical Preparations
• Founded: 1955
• Employees: 1,357
• Stock Exchange: Bucharest Stock Exchange
• Ticker Symbol: ATB

Financial Performance

In 2024, Antibiotice's revenue was 688.70 million, an increase of 11.93% compared to the previous year's 615.29 million. Earnings were 102.20 million, an increase of 26.04%.